年単位の研究成果
Fingerprint Kenzo Soejimaが取り組む研究トピックをご確認ください。これらのトピックラベルは、この人物の研究に基づいています。これらを共に使用することで、固有の認識が可能になります。
- 16 同様のプロファイル
Non-Small Cell Lung Carcinoma
Medicine & Life Sciences
Lung
Medicine & Life Sciences
Lung Neoplasms
Medicine & Life Sciences
Epidermal Growth Factor Receptor
Medicine & Life Sciences
Mutation
Medicine & Life Sciences
Protein-Tyrosine Kinases
Medicine & Life Sciences
Acute Lung Injury
Medicine & Life Sciences
Endotoxins
Medicine & Life Sciences
ネットワーク
最近の共同研究。丸をクリックして詳細を確認しましょう。
研究成果 1993 2019
- 1651 引用
- 24 h指数
- 112 Article
1
引用
(Scopus)
A phase II trial of induction of erlotinib followed by cytotoxic chemotherapy for EGFR mutation-positive non-squamous non-small cell lung cancer patients
Tani, T., Naoki, K., Yasuda, H., Arai, D., Ishioka, K., Ohgino, K., Yoda, S., Nakayama, S., Satomi, R., Terai, H., Ikemura, S., Sato, T. & Soejima, K., 2019 1 1, (Accepted/In press) ： : Cancer Chemotherapy and Pharmacology.研究成果: Article
Chemotherapy
Non-Small Cell Lung Carcinoma
Cells
Drug Therapy
Mutation
1
引用
(Scopus)
Effect of FGF/FGFR pathway blocking on lung adenocarcinoma and its cancer-associated fibroblasts
Hegab, A. E., Ozaki, M., Kameyama, N., Gao, J., Kagawa, S., Yasuda, H., Soejima, K., Yin, Y., Guzy, R. D., Nakamura, Y., Ornitz, D. M. & Betsuyaku, T., 2019 1 1, ： : Journal of Pathology.研究成果: Article
Fibroblast Growth Factor Receptors
Fibroblast Growth Factors
Neoplasms
Lung
Cancer-Associated Fibroblasts
6
引用
(Scopus)
Efficacy of afatinib or osimertinib plus cetuximab combination therapy for non-small-cell lung cancer with EGFR exon 20 insertion mutations
Hasegawa, H., Yasuda, H., Hamamoto, J., Masuzawa, K., Tani, T., Nukaga, S., Hirano, T., Kobayashi, K., Manabe, T., Terai, H., Ikemura, S., Kawada, I., Naoki, K. & Soejima, K., 2019 1 1, ： : Lung Cancer. 127, p. 146-152 7 p.研究成果: Article
Insertional Mutagenesis
Epidermal Growth Factor Receptor
Non-Small Cell Lung Carcinoma
Exons
Therapeutics
Molecular dynamics simulation-guided drug sensitivity prediction for lung cancer with rare EGFR mutations
Ikemura, S., Yasuda, H., Matsumoto, S., Kamada, M., Hamamoto, J., Masuzawa, K., Kobayashi, K., Manabe, T., Arai, D., Nakachi, I., Kawada, I., Ishioka, K., Nakamura, M., Namkoong, H., Naoki, K., Ono, F., Araki, M., Kanada, R., Ma, B., Hayashi, Y. および8人, , 2019 5 14, ： : Proceedings of the National Academy of Sciences of the United States of America. 116, 20, p. 10025-10030 6 p.研究成果: Article
公開
Molecular Dynamics Simulation
Lung Neoplasms
Mutation
Pharmaceutical Preparations
Protein-Tyrosine Kinases
Monomer preference of EGFR tyrosine kinase inhibitors influences the synergistic efficacy of combination therapy with cetuximab
Oashi, A., Yasuda, H., Kobayashi, K., Tani, T., Hamamoto, J., Masuzawa, K., Manabe, T., Terai, H., Ikemura, S., Kawada, I., Naoki, K. & Soejima, K., 2019 1 1, ： : Molecular cancer therapeutics. 18, 9, p. 1593-1601 9 p.研究成果: Article
Dimerization
Protein-Tyrosine Kinases
Non-Small Cell Lung Carcinoma
Lung Neoplasms
Therapeutics